GLP-1s for Psoriatic Arthritis (PsA) Asthma One study of more than 3,000 adults who were overweight or had obesity found that those taking a GLP-1 had a 12 to 15 percent lower risk of asthma exacerbations than those not taking these drugs
L., Endocrinologist Tirzepatide changed the field
September 15, 2025: Maryland Government Reviewing Cost Concerns for Trulicity, Other Diabetes Medications Marylands Prescription Drug Affordability Board is reviewing the cost of six diabetes and weight loss management medications, including Trulicity
These medications help slow gastric emptying, enhance insulin secretion, and reduce appetite so that patients can see more effective results
In a society already grappling with diet culture and body image pressures, the pursuit of an ideal body shape through medication, especially by those who are not clinically overweight or obese, can exacerbate existing body dysmorphia and contribute to the development or worsening of eating disorders
With people shedding up to 20% of their weight during clinical trials and the highest doses causing nearly a 29% reduction, experts are optimistic this drug could revolutionize obesity treatment for menopausal women